Some thread this - and food for thought for new USPTO Director Iancu ... https://t.co/tskatS6430
Take part in IAM's benchmarking survey for a chance to win a free delegate place at IPBC Global: https://t.co/ft0dXw3U9U
So farewell, then, the sovereign immunity workaround at the PTAB.
Responses have been flowing in since the 2018 IAM benchmarking survey was launched two weeks ago. If you haven’t done so already, try to find 15 minutes to have your say on the critical issues and trends currently affecting the global IP market in areas such as transactions, patent quality, patent office performance, policy and litigation. Your participation will help to shine a...
InterDigital announced its 2017 financials yesterday and while they didn’t match last year’s blockbuster performance, the company still saw total income of a little over $530 million. Although that was down from $665.9 million in 2016, its licensing agreement with LG Electronics signed in December helped boost recurring revenues for the fourth quarter to $99.1 million (up from...
A recent report from the US president’s executive office on reducing drug prices makes reassuring reading for innovators concerned about the future of pharmaceutical patents under the Trump administration. In contrast to comments previously made by the president and his new health secretary Alex Azar, the paper robustly defends innovators’ IP rights, while recommending regulatory...
Matt Stack has spent much of his investment career developing a keen understanding of just how valuable intellectual property can be to a company. But as patents become far less enticing, he has shifted his focus to a new and very different kind of intangible asset
IAM Patent 1000
The definitive guide to leading patent lawyers, attorneys and firms in over 40 jurisdictions, with a special section on expert witnesses in the United States.Visit site